In this video, Douglas Jones, MD, Director of Rocky Mountain Allergy at Tanner Clinic, discusses some of the recent developments on the study and treatment of hereditary angioedema, including the ...

Hereditary angioedema (HAE) is a condition that causes swelling, or edema, in different parts of the body. It mainly affects the upper respiratory tract, skin, and abdomen. HAE is a type of ...

The leading Hereditary Angioedema Companies such as Corcept Therapeutics, BioCryst Pharmaceuticals, KalVista Pharmaceuticals, ...

Idiopathic angioedema (swelling with an unknown cause) can be caused by stress or infection. Symptoms of angioedema usually appear rapidly and may include: ...

This AAEM Clinical Practice Guideline is intended for use with patients presenting to the ED with a chief complaint of acute urticaria and/or angioedema.

Angioedema on a man’s upper lip Oral administration of BCX7353 at dose of 125 mg results in lower rate of attacks vs placebo. HealthDay News) — A small-molecule inhibitor of plasma kallikrein ...

Ionis on Thursday said the FDA green light covers Dawnzera for prophylaxis to prevent attacks of hereditary angioedema in patients 12 years of age and older and makes the drug is the first and only ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema.

Ionis Pharmaceuticals’ investigational treatment for hereditary angioedema (HAE) has hit the primary endpoint of a phase 3 trial, allowing the biotech to ready its approval application to the ...